Showing 51-60 of 1328 results for "".
Dupixent, Juvéderm Vollure XC, Bavencio Approvals
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-dupixent-juv-derm-vollure-xc-bavencio-approvals/18698/The FDA has approved Regeneron's injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It will be marketed by Regeneron and Sanofi Genzyme in the US. Allergan's Juvéderm Vollure XC has received FDA approval based on a pivotal clinical trial in which 59 percent of subjects sActinic Keratosis: Therapy Overview
https://practicaldermatology.com/topics/skin-cancer-photoprotection/actinic-keratosis-therapy-overview/19732/Joel Cohen, MD interviews George Martin, MD about the latest developments in actinic keratosis. Dr. Martin said he is eagerly awaiting regulatory review of tirbanibulin, which showed promising results in clinical trials. The two also discuss practical tips and nuances of using 5FU in practice. *Be sHow Artificial Intelligence and Chatbots are Enhancing Medical Experiences for Patients
https://practicaldermatology.com/topics/practice-management/how-artificial-intelligence-and-chatbots-are-enhancing-medical-experiences-for-patients/23570/Medical practices are leveraging technology to increase patient care and overall efficiencies to improve the all-around customer experience.Recap of Maui Derm Hawaii Meeting
https://practicaldermatology.com/series/dermwire-tv/recap-of-maui-derm-hawaii-meeting/32717/In this week's DermwireTV, key stakeholders in dermatology gather in Hawaii to discuss the latest developments and advances; a new review examines whether IgE-targeting therapies could represent a new treatment avenue for psoriasis and atherosclerosis; and the founder of SEEN hair care joProviding the Best Outcomes with Dermal Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/glaser/18972/What can we look forward to in the way of fillers in the year ahead? According to Dee Anna Glaser, MD, there may be several new tools in your tool chest, but in the end, it's how they're utilized that's most important. Dr. Glaser, Vice Chairman, Dept. of Dermatology, St. Louis University School ofThe State of AI in Dermatology
https://practicaldermatology.com/issues/january-february-2025/the-state-of-ai-in-dermatology/32927/The term “artificial intelligence” (AI) has been inescapable since OpenAI released ChatGPT to the public in November 2022.Vegas Cosmetic Surgery 2016 Update
https://practicaldermatology.com/topics/practice-management/vegas-cosmetic-surgery-2016-update/18764/Highlights from the Vegas Cosmetic Surgery 2016 meeting at the Bellagio hotel. Get insights from speakers: Timothy Miller, MD, Jason Bloom, MD, Jeffrey Spiegel, MD, David Evans, Mara Shorr, BS, CAC II-VII, Donn Chatham, MD, Wendy Lee, MD, Jay Shorr, BA, MBM-C, CAC I-VIII. Topics include neurotoxins,Dr. Joel Schlessinger's Tips for Hiring
https://practicaldermatology.com/topics/practice-management/dr-joel-schlessinger-39-s-tips-for-hiring/19295/In this video, Dr. Joel Schlessinger offers his advice for hiring employees. When finding new staff for his own practice, Dr. Joel Schlessinger makes sure each employee is a great fit for his organization. He puts each candidate through a test to find out if he or she is detail oriented, makes a poiLaser Techniques: What’s Hot
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-techniques-what-rsquo-s-hot/19146/Joel L. Cohen, MD, discusses the use of devices for fat rejuvenation techniques with Mat Avram, MD, Director of Massachusetts General Hospital Laser & Cosmetic Center in Boston. Dr. Avram describes how speaking with colleagues and doing one's homework will further assist in choosing the proper dJournal Club: Tapinarof Cream in Pediatric Patients
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-tapinarof-cream-in-pediatric-patients/32399/Practical Dermatology Editorial Board member Peter Lio, MD, speaks with Mona Shahriari, MD, about the Journal of Dermatology article "A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis," and the general importance of